196 related articles for article (PubMed ID: 38329441)
1. Mechanism of Erianin anti-triple negative breast cancer based on transcriptomics methods and network pharmacology.
Li M; Zhao Y; Li H; Kang S; Deng X; Sheng M
Aging (Albany NY); 2024 Feb; 16(3):2848-2865. PubMed ID: 38329441
[TBL] [Abstract][Full Text] [Related]
2. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
3. Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway.
Xu Y; Fang R; Shao J; Cai Z
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34036307
[TBL] [Abstract][Full Text] [Related]
4. Integrated component identification, network pharmacology, and experimental verification revealed mechanism of Dendrobium officinale Kimura et Migo against lung cancer.
Zhao Y; Zhu S; Li Y; Niu X; Shang G; Zhou X; Yin J; Bao B; Cao Y; Cheng F; Li Z; Wang R; Yao W
J Pharm Biomed Anal; 2024 Jun; 243():116077. PubMed ID: 38460276
[TBL] [Abstract][Full Text] [Related]
5. Erianin inhibits human lung cancer cell growth via PI3K/Akt/mTOR pathway in vitro and in vivo.
Zhang HQ; Xie XF; Li GM; Chen JR; Li MT; Xu X; Xiong QY; Chen GR; Yin YP; Peng F; Chen Y; Peng C
Phytother Res; 2021 Aug; 35(8):4511-4525. PubMed ID: 34236105
[TBL] [Abstract][Full Text] [Related]
6. Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways.
Yang L; Hu Y; Zhou G; Chen Q; Song Z
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677672
[TBL] [Abstract][Full Text] [Related]
7. Erianin inhibits the progression of triple-negative breast cancer by suppressing SRC-mediated cholesterol metabolism.
Li M; Kang S; Deng X; Li H; Zhao Y; Tang W; Sheng M
Cancer Cell Int; 2024 May; 24(1):166. PubMed ID: 38734640
[TBL] [Abstract][Full Text] [Related]
8. Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer.
Zhao M; Fu L; Xu P; Wang T; Li P
Drug Des Devel Ther; 2023; 17():901-917. PubMed ID: 36998242
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism of Ruxian Shuhou prescription in the treatment of triple-negative breast cancer based on network pharmacology.
Chu M; Meng T; Zhou Y; Jin L; Dai Q; Ma L; Chen H
Medicine (Baltimore); 2023 Sep; 102(35):e34763. PubMed ID: 37657065
[TBL] [Abstract][Full Text] [Related]
10. Curcumin suppresses metastasis of triple-negative breast cancer cells by modulating EMT signaling pathways: An integrated study of bioinformatics analysis.
Chen Z; Lu P; Li M; Zhang Q; He T; Gan L
Medicine (Baltimore); 2024 Feb; 103(8):e37264. PubMed ID: 38394486
[TBL] [Abstract][Full Text] [Related]
11. MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway.
Wei S; Zhang Y; Ma X; Yao Y; Zhou Q; Zhang W; Zhou C; Zhuang J
Sci Rep; 2023 Jul; 13(1):12351. PubMed ID: 37524857
[TBL] [Abstract][Full Text] [Related]
12. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
13. Sophoraflavanone G suppresses the progression of triple-negative breast cancer via the inactivation of EGFR-PI3K-AKT signaling.
Cheng W; Liu D; Guo M; Li H; Wang Q
Drug Dev Res; 2022 Aug; 83(5):1138-1151. PubMed ID: 35426453
[TBL] [Abstract][Full Text] [Related]
14. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
15. Integrated plasma pharmacochemistry and network pharmacology to explore the mechanism of Gerberae Piloselloidis Herba in treatment of allergic asthma.
Zhou K; Lu D; You J; Liu T; Sun J; Lu Y; Pan J; Li Y; Liu C
J Ethnopharmacol; 2022 Nov; 298():115624. PubMed ID: 35970314
[TBL] [Abstract][Full Text] [Related]
16. Exploration of the Pharmacological Mechanism of Vitexicarpin against Triple-Negative Breast Cancer in Network Pharmacology.
Wu T; Xiang M; Li Y; Gao Y; Teng D; Sun M; Guo W; Zhou Y
Front Biosci (Landmark Ed); 2023 Dec; 28(12):341. PubMed ID: 38179762
[TBL] [Abstract][Full Text] [Related]
17. Erianin regulates programmed cell death ligand 1 expression and enhances cytotoxic T lymphocyte activity.
Yang A; Li MY; Zhang ZH; Wang JY; Xing Y; Ri M; Jin CH; Xu GH; Piao LX; Jin HL; Zuo HX; Ma J; Jin X
J Ethnopharmacol; 2021 Jun; 273():113598. PubMed ID: 33220359
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of oroxyli semen against triple-negative breast cancer verified by bioinformatics and in vitro experiments.
Chen L; Yang A; Li Y; Liu X; Jiang W; Hu K
Medicine (Baltimore); 2023 Sep; 102(37):e34835. PubMed ID: 37713894
[TBL] [Abstract][Full Text] [Related]
19. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies.
Mu BX; Li Y; Ye N; Liu S; Zou X; Qian J; Wu C; Zhuang Y; Chen M; Zhou JY
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117342. PubMed ID: 37879505
[TBL] [Abstract][Full Text] [Related]
20. The mechanism and experimental verification of Ixeris sonchifolia promoting apoptosis of hepatocellular carcinoma based on network pharmacology: Ixeris sonchifolia Induces Hepatocellular Carcinoma Apoptosis via the PI3K/AKT Pathway.
Liu BJ; Guan YY; Qiao LX; Zhang JM; Li AJ; Yang PX; Gao YX; Chen DX; Wang CX; Wu J
J Ethnopharmacol; 2024 Jun; 327():117994. PubMed ID: 38437889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]